Lucinda Carr

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

Yael Hacohen, Sukhvir Wright, Patrick Waters et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 258 citations · Full text

Malfunction of Nuclease ERCC1-XPF Results in Diverse Clinical Manifestations and Causes Cockayne Syndrome, Xeroderma Pigmentosum, and Fanconi Anemia

Kazuya Kashiyama, Yuka Nakazawa, Daniela T. Pilz et al. · The American Journal of Human Genetics · 2013 · 203 citations · Full text

Fanconi Anemia, Genetics, Hematology +5

Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study

Richard Baker, Miłosz Jasiński, Iwona Maciąg-Tymecka et al. · Developmental Medicine & Child Neurology · 2002 · 144 citations

Botulinum Toxin Treatment, Cerebral Palsy, Dose-ranging Study +18

Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double‐blind, placebo‐controlled, dose‐ranging study

Richard Baker, Miłosz Jasiński, Iwona Maciąg-Tymecka et al. · Developmental Medicine & Child Neurology · 2002 · 134 citations · Full text

Neuromuscular Coordination, Botulinum Toxin Treatment, Neuromodulation Therapies +27

Is the mitochondrial complex I ND5 gene a hot‐spot for MELAS causing mutations?

Danae Liolitsa, S. Rahman, Sarah Benton et al. · Annals of Neurology · 2002 · 124 citations